Lysophosphatidic acid (LPA) acts through high affinity G protein-coupled receptors to mediate a plethora of physiological and pathological activities associated with tumorigenesis. LPA receptors and autotaxin (ATX/LysoPLD), the primary enzyme producing LPA, are aberrantly expressed in multiple cancer lineages. However, the role of ATX and LPA receptors in the initiation and progression of breast cancer has not been evaluated. We demonstrate that expression of ATX or each Edg-family LPA receptor in mammary epithelium of transgenic mice is sufficient to induce a high frequency of late-onset, estrogen receptor (ER) positive, invasive and metastatic mammary cancer. Thus ATX and LPA receptors can contribute to the initiation and progression of b...
Autotaxin (ENPP2/ATX) and lysophosphatidic acid (LPA) receptors represent two key players in regulat...
Bone metastases are highly frequent complications of breast cancers. Current bone metastasis treatme...
Lysophosphatidic acid (LPA) is a lipid mediator with a wide variety of biological actions, particula...
Lysophosphatidic acid (LPA) acts through high affinity G protein-coupled receptors to mediate a plet...
SummaryLysophosphatidic acid (LPA) acts through high-affinity G protein-coupled receptors to mediate...
Previous studies provide high evidence that autotaxin (ATX)-lysophosphatidic acid (LPA) signaling th...
Lysophosphatidic acid (LPA) is a lipid growth factor that is produced by an extracellular phospholip...
Les métastases sont des conséquences dramatiques lors de la progression des cancers. Malgré les trai...
Metastases consist of poor disease progression for patients with cancers. Bone metastases are freque...
Purpose: We evaluated the expression of autotaxin-lysophosphatidate signaling-related proteins and t...
Metastasis is the main cause of death for cancer patients. Targeting factors that control metastasis...
Background Breast cancer is the most common malignancy in women affecting one out of eight female...
Autotaxin (ENPP2/ATX) and lysophosphatidic acid (LPA) receptors represent two key players in regulat...
This research aimed to evaluate the expression and clinical implication of autotaxin (ATX)-lysophosp...
Lysophospholipids have long been recognized as membrane phospholipid metabolites, but only recently ...
Autotaxin (ENPP2/ATX) and lysophosphatidic acid (LPA) receptors represent two key players in regulat...
Bone metastases are highly frequent complications of breast cancers. Current bone metastasis treatme...
Lysophosphatidic acid (LPA) is a lipid mediator with a wide variety of biological actions, particula...
Lysophosphatidic acid (LPA) acts through high affinity G protein-coupled receptors to mediate a plet...
SummaryLysophosphatidic acid (LPA) acts through high-affinity G protein-coupled receptors to mediate...
Previous studies provide high evidence that autotaxin (ATX)-lysophosphatidic acid (LPA) signaling th...
Lysophosphatidic acid (LPA) is a lipid growth factor that is produced by an extracellular phospholip...
Les métastases sont des conséquences dramatiques lors de la progression des cancers. Malgré les trai...
Metastases consist of poor disease progression for patients with cancers. Bone metastases are freque...
Purpose: We evaluated the expression of autotaxin-lysophosphatidate signaling-related proteins and t...
Metastasis is the main cause of death for cancer patients. Targeting factors that control metastasis...
Background Breast cancer is the most common malignancy in women affecting one out of eight female...
Autotaxin (ENPP2/ATX) and lysophosphatidic acid (LPA) receptors represent two key players in regulat...
This research aimed to evaluate the expression and clinical implication of autotaxin (ATX)-lysophosp...
Lysophospholipids have long been recognized as membrane phospholipid metabolites, but only recently ...
Autotaxin (ENPP2/ATX) and lysophosphatidic acid (LPA) receptors represent two key players in regulat...
Bone metastases are highly frequent complications of breast cancers. Current bone metastasis treatme...
Lysophosphatidic acid (LPA) is a lipid mediator with a wide variety of biological actions, particula...